Premium
A novel biallelic splice‐site variant in the LRP4 gene causes sclerosteosis 2
Author(s) -
BukowskaOlech Ewelina,
SowińskaSeidler Anna,
Szczałuba Krzysztof,
Jamsheer Aleksander
Publication year - 2020
Publication title -
birth defects research
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.845
H-Index - 17
ISSN - 2472-1727
DOI - 10.1002/bdr2.1676
Subject(s) - syndactyly , biology , exome sequencing , genetics , splice site mutation , mutation , in silico , rna splicing , gene , rna
Abstract The LRP4 gene encodes the highly conserved low‐density lipoprotein receptor‐related protein 4 (LRP4), which acts as a co‐receptor for sclerostin. Sclerostin and LRP4 negatively regulate WNT/β‐catenin signaling pathway and lack of their inhibitory activity leads to constant osteoblastic differentiation. Consequently, increased bone formation occurs, which in the case of LRP4 mutations results in sclerosteosis type 2 (SOST2). Alterations within the LRP4 may also cause Cenani‐Lenz syndactyly syndrome (CLSS), congenital myasthenia or isolated syndactyly. Here, we have reported a patient, in whom we found a novel homozygous splice‐site variant c.1048+6T>C in LRP4 using whole exome sequencing. The patient was initially misdiagnosed with isolated CLSS‐like or Malik‐Percin‐like syndactyly. However, we have finally refined the diagnosis after comprehensive radiological examination and molecularly confirmed SOST2. Additionally, we have pointed here to the splicing variants as important causative alterations that may be overlooked in the molecular analysis due to the lack of advanced, reliable algorithms, built‐into the standard diagnostic pipelines. Using advanced in silico prediction tools of splice‐site alterations, including Alamut Visual software, we have demonstrated that the c.1048+6T>C LRP4 variant affects the native donor site and impairs an SC35 enhancer activity. Based on our experience, we recommend comprehensive radiological imaging, including X‐ray of the skull in each case of isolated syndactyly resulting from pathogenic variants of LRP4 . We suggest that all previously reported patients carrying biallelic LRP4 mutations, who were diagnosed with isolated syndactyly, could actually present with SOST2 that had been unrecognized due to the incomplete clinical and radiological assessment.